Active Not Recruiting PHASE1 INTERVENTIONAL 1-arm NCT05947474

ORB-011 In Patients With Advanced Solid Tumors (ORB)

Sponsor: Orionis Biosciences Inc

Interventions ORB-011

Updated 9 times since 2023 Last updated: Feb 9, 2026 Started: Aug 21, 2023 Primary completion: Mar 31, 2026 Completion: Mar 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Advanced Solid Cancer, this trial is ongoing. The trial is conducted by Orionis Biosciences Inc and has accumulated 9 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

9 versions recorded

Feb 2026 — Present [monthly]

Active Not Recruiting PHASE1
Sep 2025 — Feb 2026 [monthly]

Active Not Recruiting PHASE1
May 2025 — Sep 2025 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting
Apr 2025 — May 2025 [monthly]

Recruiting PHASE1
Sep 2024 — Apr 2025 [monthly]

Recruiting PHASE1

▶ Show 4 earlier versions

Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1
Oct 2023 — Jul 2024 [monthly]

Recruiting PHASE1
Sep 2023 — Oct 2023 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Aug 2023 — Sep 2023 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Orionis Biosciences Inc

Data source: Orionis Biosciences Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States
• Scottsdale, United States